Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;40(11):474-480.
doi: 10.1016/j.urolonc.2020.05.001. Epub 2020 May 24.

Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomes

Hilary L Robertson  1 , Carrie Michel  1 , Lucas Bartl  1 , Jill M Hamilton-Reeves  2
Affiliations
Review

Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomes

Hilary L Robertson et al. Urol Oncol. 2022 Nov.

Abstract

Sarcopenia is the loss of muscle mass and function related to aging, undereating, disease conditions, or inactivity. Pre-existing sarcopenia diminishes the functional reserve of patients with cancer which increases their risk for frailty, cancer cachexia, and worse outcomes from treatments. The pathogenesis of sarcopenia is multi-factorial: opening opportunities for clinicians to work across disciplines to improve patient outcomes and quality of life. The purpose of this essay is to describe sarcopenia, discuss clinical screening and assessment for sarcopenia, and highlight potential interventions to manage sarcopenia in the urologic oncology population.

Keywords: Cachexia; Exercise; Frailty; Malnutrition; Nutrition; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None of the authors had conflicts of interests to report.

References

    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM et al. : Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412–423. - PMC - PubMed
    1. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ et al. : Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011, 12(6):403–409. - PMC - PubMed
    1. Chindapasirt J: Sarcopenia in Cancer Patients. Asian Pac J Cancer Prev 2015, 16(18):8075–8077. - PubMed
    1. Rimar KJ, Glaser AP, Kundu S, Schaeffer EM, Meeks J, Psutka SP: Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer. Bladder Cancer 2018, 4(4):411–418. - PMC - PubMed
    1. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC et al. : Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. J Urol 2016, 195(2):270–276. - PubMed

Publication types